Turkey Diagnostics Imaging Market, By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions), By Mobility (Portable, Standalone), By Source (Domestic, Import), By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

Turkey Diagnostics Imaging market was valued at USD 545.15 Million in 2024 and is expected to reach USD 685.46 Million by 2030 with a CAGR of 3.85%. The Turkey Diagnostic Imaging Market is undergoing robust growth, propelled by a convergence of demographic shifts, escalating healthcare demand, and advancements in imaging technology. The market spans a comprehensive range of modalities, including X-ray, MRI, CT scanners, ultrasound, and nuclear imaging solutions, catering to diverse diagnostic needs. The rising focus on early disease detection, coupled with the increased prevalence of chronic conditions and a rapidly aging population, positions Turkey as a key player within the regional healthcare landscape.

This market offers substantial growth prospects, driven by Turkey's evolving healthcare requirements, technological adoption, and strategic investments in healthcare infrastructure. As the country addresses the rising burden of chronic diseases, oncological cases, and the specific demands of an aging demographic, the diagnostic imaging sector is poised to remain a central pillar of Turkey's healthcare framework. This dynamic environment presents significant opportunities for both established industry leaders and emerging players to capitalize on Turkey's evolving healthcare needs and its commitment to advanced diagnostic solutions.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is one of the most influential and sustained growth drivers for the Turkey Diagnostic Imaging Market. In Turkey, the healthcare system faces a substantial challenge due to the high incidence of chronic diseases, which now account for a majority of all-cause mortality. Notably, chronic kidney disease (CKD) affects approximately 15.7% of the population, underscoring a critical and growing demand for continuous diagnostic monitoring and advanced imaging support.  Chronic diseases such as cardiovascular disorders, cancer, diabetes, and chronic respiratory conditions are on the rise in Turkey, driven by factors such as sedentary lifestyles, unhealthy diets, smoking, urbanization, and genetic predisposition. In 2022, Turkey recorded 240,013 newly diagnosed cancer cases across both genders, reflecting a significant clinical workload. The age-standardized incidence rate (ASR) stood at 225 per 100,000 population, indicating a sustained rise in oncology-related healthcare demand. These conditions typically require early and accurate diagnosis for effective treatment planning and disease management. Diagnostic imaging techniques such as MRI, CT scans, X-rays, and ultrasound play a central role in: Initial diagnosis, Disease staging, Progress monitoring, Post-treatment assessment. This leads to repeat and long-term utilization of imaging equipment, thereby increasing the volume and frequency of diagnostic procedures conducted in hospitals and imaging centers.

With chronic diseases becoming more prevalent, the healthcare landscape in Turkey is gradually shifting from reactive to preventive and personalized care. Imaging is a key enabler in this transition, offering non-invasive, precise, and real-time insights into internal pathologies. As medical professionals focus on risk-based screenings and proactive health management, especially for high-risk groups, diagnostic imaging is increasingly being used as a routine part of care protocols particularly for: Cancer screenings (e.g., mammograms, CT lung scans), Cardiovascular risk assessments (e.g., echocardiography, angiography), Diabetes-related complications (e.g., retina imaging, foot and kidney assessments). This sustained clinical reliance on imaging technologies fuels continuous market expansion. The increasing burden of chronic diseases places significant strain on the Turkish healthcare system, prompting public health authorities and private players to invest more heavily in diagnostic infrastructure. Hospitals are upgrading their imaging departments. Diagnostic centers are expanding into semi-urban and rural areas. Government programs are promoting wider access to diagnostic services through state-funded insurance schemes and public-private partnerships. These systemic changes are increasing installed imaging capacity, which in turn supports long-term market growth. Many chronic conditions require multi-modality diagnostics0020where multiple imaging techniques are used together to provide a comprehensive clinical picture. A cancer patient may require an ultrasound for lump detection, a CT scan for staging, and an MRI for soft tissue evaluation. Cardiovascular patients may need X-rays, echocardiograms, and nuclear imaging. This layered approach leads to higher imaging volumes per patient, boosting overall utilization rates of imaging equipment and increasing revenue opportunities for healthcare providers and imaging equipment suppliers.

Aging Population

The aging population is a major structural driver contributing to the sustained expansion of the Turkey Diagnostic Imaging Market. Turkey is experiencing a notable demographic transformation, with the aging population becoming a significant factor in shaping healthcare demand. The proportion of individuals aged 65 and above has grown from 8.8% in 2018 to 10.2% in 2023, signaling an ongoing shift towards an older population. As individuals age, they become increasingly vulnerable to a wide range of chronic and degenerative conditions, including Cardiovascular diseases, Osteoporosis and joint disorders, Neurological disorders such as Alzheimer’s and Parkinson’s, Various forms of cancer, Pulmonary and renal dysfunctions. These conditions require frequent and detailed diagnostic imaging for detection, monitoring, and treatment evaluation. Modalities such as MRI, CT scans, X-rays, bone densitometry (DEXA), and ultrasound are commonly used in geriatric care. As a result, a larger elderly population automatically leads to greater demand for these imaging services. In Turkey, healthcare service utilization, particularly physician visits, remains notably high relative to other developed nations. The country has consistently recorded robust per capita physician visit rates, with figures of 8.6 in 2016, 8.9 in 2017, 9.5 in 2018, and 9.8 in 2019. This trend reflects a strong demand for healthcare access, driven by a high level of patient engagement with medical services. Older adults typically have higher rates of healthcare utilization, both in terms of hospital visits and diagnostic procedures. They often require: Regular screenings, Follow-up imaging for chronic disease management, Pre- and post-surgical assessments, Emergency imaging (e.g., stroke, fractures, heart attacks). This leads to a higher per capita imaging rate among the elderly compared to younger demographics, thereby fueling volume growth in diagnostic imaging centers and hospitals across Turkey.

The elderly population often requires specialized imaging technologies tailored to their medical needs. Low-dose CT scans to minimize radiation exposure, Advanced MRI techniques to detect early neurodegenerative changes, Bone mineral density tests (DEXA) for osteoporosis, Ultrasound and Doppler imaging for vascular and abdominal conditions. This need for targeted, safe, and high-resolution imaging is prompting healthcare facilities to upgrade equipment and adopt new technologies a trend that drives capital investment and market growth. Turkey’s healthcare system is gradually evolving to accommodate its aging population. Establishment of geriatric departments in hospitals, Growth of elder care homes and specialized clinics, Government initiatives promoting preventive screenings for the elderly. As geriatric healthcare infrastructure expands, diagnostic imaging becomes an essential component of care delivery, further increasing the installed base and utilization of imaging technologies.

Download Free Sample Report

Key Market Challenges

High Capital and Operational Costs

Diagnostic imaging technologies such as MRI, CT, PET-CT, and digital X-ray systems require significant upfront investment. In addition to procurement costs, there are ongoing operational expenses related to: Maintenance and servicing of high-tech equipment, Upgrades and calibration, Skilled personnel training and retention, Compliance with safety and quality regulations.

These high costs pose a barrier to wider adoption in small- and mid-sized healthcare facilities, especially in semi-urban and rural areas. Public hospitals often rely on government budgets or public-private partnerships (PPPs), while private diagnostic centers may struggle to balance quality with profitability. The long payback periods and unpredictable patient volumes also limit the willingness of private investors to enter or expand within the imaging sector. This restricts market penetration and slows infrastructure development outside major metropolitan areas.

Uneven Access and Regional Disparities

Access to advanced diagnostic imaging remains uneven across Turkey, with a concentration of modern imaging facilities in urban centers like Istanbul, Ankara, and Izmir. In contrast, rural and remote regions often face: Shortages of imaging infrastructure, Limited availability of trained radiologists and technicians, Delays in image interpretation and reporting.

This geographic imbalance creates inequitable healthcare delivery and limits the overall utilization of imaging technologies at the national level. Patients in underserved areas may face long wait times or be forced to travel to larger cities for diagnostic procedures, which discourage timely screenings and early diagnosis. The resulting underutilization of imaging services in certain regions hinders national market growth and prevents the industry from achieving scale and efficiency.

Key Market Trends

Strategic Expansion of City Hospitals (Şehir Hastaneleri) with Integrated Imaging Hubs

A key structural transformation in Turkey’s healthcare sector is the development of large-scale, government-backed city hospitals under Public-Private Partnership (PPP) models. These mega hospitals are designed as centralized, high-capacity medical ecosystems that include dedicated diagnostic imaging hubs equipped with advanced imaging suites (MRI, CT, PET-CT, Interventional Radiology, etc.). Unlike standalone hospitals, these city hospitals offer high patient throughput, which supports the economic viability of expensive imaging equipment. Moreover, they function as referral centers for regional healthcare networks, ensuring a steady and diverse caseload from trauma and cancer to prenatal diagnostics.

Creates sustained demand for high-end imaging solutions and service contracts, Encourages vendor partnerships and long-term leasing models for equipment providers, Sets the standard for digital integration and imaging informatics, prompting upgrades in surrounding hospitals. This trend is unique to Turkey's healthcare policy landscape and is a defining driver for future equipment procurement, software integration, and managed imaging services.

Surge in Radiology Outsourcing and Teleradiology Networks

Turkey is experiencing a critical shortage of qualified radiologists, particularly in Tier-2 and Tier-3 cities. In response, healthcare providers both public and private are increasingly adopting radiology outsourcing models, including teleradiology, where image interpretation is performed remotely by radiologists located in urban centers or abroad. This is not simply a workforce workaround it is creating a new service layer in the diagnostic imaging value chain. Radiology-as-a-service platforms are emerging, combining AI-based pre-screening tools, Secure PACS (Picture Archiving and Communication Systems), Cloud-based diagnostic workflows. Expands imaging access to underserved regions without needing local radiologists. Stimulates demand for interoperable imaging platforms, cloud PACS, and secure data transfer systems. Opens up B2B revenue streams for private radiology firms and imaging service providers. This trend reflects a shift from hardware-driven to service-oriented market dynamics, with scalable, subscription-based imaging services becoming increasingly common.

Segmental Insights

Type Insights

Based on the category of Type, the MRI Systems segment emerged as the fastest growing segment in the Turkey Diagnostics Imaging Market in 2024. Magnetic Resonance Imaging (MRI) has become the modality of choice for evaluating complex neurological, orthopedic, and soft tissue conditions — areas where precision and tissue contrast are critical. Increasing incidence of neurological disorders such as stroke, multiple sclerosis, and Alzheimer’s disease in Turkey’s aging population. Surge in sports injuries, arthritis, and spinal conditions require detailed soft tissue imaging. MRI is also widely used in pre-surgical planning and post-operative monitoring, especially in orthopedic and neuro-oncology fields. These clinical trends are pushing both public hospitals and private diagnostic centers to upgrade or expand their MRI capabilities, leading to strong segmental growth.

Turkey's Ministry of Health has made strategic investments in high-end medical imaging infrastructure as part of its healthcare modernization program, especially within city hospitals and tertiary referral centers. Deployment of 1.5T and 3T MRI machines in newly built public hospitals. Public-private partnerships (PPPs) enabling financing and installation of MRI units across large hospitals. Favorable procurement policies under the Social Security Institution (SGK) which support access to advanced diagnostics. This trend is creating institutional demand for MRI systems, positioning the modality as a standard diagnostic asset in major healthcare facilities across Turkey. These factors are expected to drive the growth of this segment.

Application Insights

Based on the category of Application, the Oncology segment emerged as the dominating segment in the Turkey Diagnostics Imaging Market in 2024. Cancer is one of the leading causes of morbidity and mortality in Turkey, with rising prevalence of lung, breast, colorectal, and prostate cancers. Urban lifestyle changes, aging demographics, and environmental factors contributing to cancer risk. Government-reported increase in new cancer diagnoses annually. Early detection campaigns encouraging population-wide screenings.

This epidemiological shift has placed oncology imaging at the forefront of clinical demand, leading to high-volume use of: CT scans and MRIs for tumor localization and staging, PET-CT scans for metabolic imaging and metastasis detection, Ultrasound and mammography for breast and reproductive cancers. These procedures are essential across diagnosis, treatment planning, and ongoing monitoring, ensuring continuous usage throughout the patient journey.

The Turkish Ministry of Health actively promotes cancer prevention and early detection through nationwide screening programs for: Breast cancer (mammography), Cervical cancer (HPV/Pap smear, ultrasound), Colorectal cancer (colonoscopy supported by imaging if needed). The deployment of KETEM centers (Cancer Early Diagnosis, Screening, and Training Centers). Mobile units using portable imaging equipment for rural and underserved areas. Integration of imaging in follow-up protocols for patients with positive screening results. These initiatives have led to a surge in demand for diagnostic imaging in oncology, especially for modalities used in screening and confirmation phases. The result is sustained procedural volume and imaging center throughput in both the public and private sectors.

Download Free Sample Report

Regional Insights

The Marmara Region, home to Istanbul and several other economic hubs, stands out as the largest and most influential market in the Turkey Diagnostic Imaging Market. This dominance is the result of a synergistic mix of demographic density, economic leadership, healthcare infrastructure maturity, and private sector investment factors that make the region a central driver of imaging demand and technological adoption.

The Marmara Region is the most populous and urbanized region in Turkey, accounting for over 25% of the national population, with Istanbul alone hosting more than 15 million residents. High patient volumes across urban centers lead to increased utilization of diagnostic services. Greater prevalence of lifestyle-related and age-related diseases in dense, urban populations. High awareness and accessibility to healthcare prompt earlier diagnostic interventions. This concentration of people and disease burden ensures a steady and diverse demand for imaging services, ranging from routine radiology to advanced oncology and cardiology imaging.

The Marmara Region, particularly Istanbul, is home to the highest concentration of private hospitals, diagnostic imaging chains, and medical tourism centers in Turkey. Leading private hospital groups (e.g., Acıbadem, Memorial, Medicana) are headquartered or heavily invested in Marmara. A competitive healthcare market encourages constant investment in cutting-edge imaging technologies, such as AI-integrated MRI and PET-CT scanners. High-income populations and international patients seek premium imaging services, further fueling demand. This market-oriented environment supports faster technology adoption cycles, higher procedural volumes, and a more diversified imaging portfolio, making Marmara the most commercially attractive region

Recent Developments

• In December 2024- Memorial Hospitals Group in Turkey has strategically partnered with Aiforia Technologies Plc to integrate AI-assisted clinical diagnostics into its pathology services. This collaboration will leverage Aiforia's regulatory-approved clinical AI solutions to enhance the analysis of tissue samples, particularly for breast, prostate, and lung cancer patients at Memorial Pathology. By utilizing Aiforia's advanced AI technology, Memorial Hospitals Group aims to improve the accuracy and efficiency of its diagnostic processes, marking a significant step towards the integration of artificial intelligence in precision oncology diagnostics.
• In June 2024, Genoks, a prominent Turkish genomics healthcare firm, has entered into a strategic partnership with Velsera, a global leader in healthcare technology known for its universal software platform that bridges clinical care and scientific discovery. This collaboration is focused on advancing cancer diagnostics and treatment capabilities across Turkey and surrounding regions. By combining Genoks' expertise in genomics with Velsera's cutting-edge platform, the partnership aims to enhance personalized cancer care, streamline diagnostic workflows, and accelerate the development of precision oncology solutions in the region.   

Key Market Players

• Canon Medical Systems Corporation Turkey
• XERA MEDICAL SYSTEMS & TECHNOLOGY CO. LTD
• FUJIFILM DIS TICARET AS
• GE HealthCare Technologies Inc
• Siemens Healthineers Hakkında
• Turk Philips Ticaret AS
• SHIMADZU Middle East & Africa
• Toshiba Medical Systems Corporation ("TMSC")
• Inter-Med A.S
• Esaote Biomedica Medical Systems Inc

Report Scope:

In this report, the Turkey Diagnostics Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Turkey Diagnostics Imaging Market, By Type:

o   X-Ray Imaging Solutions

o   Ultrasound Systems

o   MRI Systems

o   CT Scanners

o   Nuclear Imaging Solutions

• Turkey Diagnostics Imaging Market, By Mobility:

o   Portable

o   Standalone

• Turkey Diagnostics Imaging Market, By Source:

o   Domestic

o   Import

• Turkey Diagnostics Imaging Market, By Application:

o   Cardiology

o   Oncology

o   Neurology

o   Orthopedics

o   Gastroenterology

o   Gynecology

o   Others

• Turkey Diagnostics Imaging Market, By End User:

o   Hospitals & Clinics

o   Diagnostic Centers

o   Ambulatory Care Centers

o   Others

• Turkey Diagnostics Imaging Market, By Region:

o   Marmara Region

o   Central Anatolia

o   Eastern Anatolia Region

o   South-Eastern Anatolia Region

o   Aegean Region

o   Mediterranean Region

o   Black Sea Region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Turkey Diagnostics Imaging Market.

Available Customizations:

 Turkey Diagnostics Imaging market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).